The ICD-10 code for Nonketotic Hyperglycinemia is E72.1. In the ICD-9 coding system, the corresponding code for this condition is 270.6. Nonketotic Hyperglycinemia is a rare genetic disorder characterized by the accumulation of glycine in the body, leading to severe neurological symptoms. Proper diagnosis and coding are crucial for effective management and treatment of this condition.
Nonketotic Hyperglycinemia (NKH) is a rare genetic disorder that affects the breakdown of the amino acid glycine in the body. It is characterized by elevated levels of glycine in the blood and cerebrospinal fluid, leading to severe neurological symptoms. The International Classification of Diseases, Tenth Revision (ICD-10) provides a specific code for this condition, which is E72.39.
The ICD-10 code E72.39 falls under the category of "Other Disorders of Amino-Acid Metabolism." This code is used to classify and identify cases of nonketotic hyperglycinemia in medical records, insurance claims, and healthcare statistics. It enables healthcare providers, researchers, and policymakers to gather data and track the prevalence and impact of this disorder.
In the previous version of the ICD, the Ninth Revision (ICD-9), a specific code for nonketotic hyperglycinemia did not exist. However, healthcare professionals and researchers may have used a broader code to classify this condition, such as 270.3, which represents "Disturbances of Amino-Acid Transport and Metabolism." This code encompassed various disorders related to amino acid metabolism, including nonketotic hyperglycinemia.
It is essential to accurately code and document rare disorders like nonketotic hyperglycinemia to ensure proper diagnosis, appropriate treatment, and effective monitoring of affected individuals. The ICD-10 code E72.39 aids in this process, enabling healthcare professionals and researchers to better understand the prevalence and impact of this condition, leading to improved care and support for patients with nonketotic hyperglycinemia.